Search research articles
Contact Us
Filters
Showing results (1-10 of 43) with videos related to
Page
of 5
Sort By:
Peptides
|
January 1, 1989
Corticotropin-releasing factor (CRF) receptors in intermediate lobe of the pituitary: biochemical characterization and autoradiographic localization
D E Grigoriadis, E B De Souza
Endocrinology
|
October 1, 1989
Heterogeneity between brain and pituitary corticotropin-releasing factor receptors is due to differential glycosylation
D E Grigoriadis, E B De Souza
The Journal of Biological Chemistry
|
August 5, 1988
The brain corticotropin-releasing factor (CRF) receptor is of lower apparent molecular weight than the CRF receptor in anterior pituitary. Evidence from chemical cross-linking studies
D E Grigoriadis, E B De Souza
European Journal of Pharmacology
|
July 15, 1993
Monoamine oxidase inhibitors inhibit [3H]quinpirole binding in rat striatal membranes
B Levant, D E Grigoriadis, E B DeSouza
FEBS Letters
|
December 1, 1986
Photoaffinity labelling of dopamine D2 receptors by [3H]azidomethylspiperone
H B Niznik, D E Grigoriadis, P Seeman
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1993
[3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study
B Levant, D E Grigoriadis, E B DeSouza
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1992
Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain
B Levant, D E Grigoriadis, E B DeSouza
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 1, 1989
Effects of chronic antidepressant and benzodiazepine treatment on corticotropin-releasing-factor receptors in rat brain and pituitary
D E Grigoriadis, D Pearsall, E B De Souza
Current Pharmaceutical Design
|
April 24, 1999
Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications
J R McCarthy, S C Heinrichs, D E Grigoriadis
European Journal of Pharmacology
|
May 24, 1995
Relative affinities of dopaminergic drugs at dopamine D2 and D3 receptors
B Levant, D E Grigoriadis, E B De Souza
Page
of 5
Search research articles
Search
Showing results (1-10 of 43) with videos related to
Sort By:
Page
of 5
Peptides
|
January 1, 1989
Corticotropin-releasing factor (CRF) receptors in intermediate lobe of the pituitary: biochemical characterization and autoradiographic localization
D E Grigoriadis, E B De Souza
Endocrinology
|
October 1, 1989
Heterogeneity between brain and pituitary corticotropin-releasing factor receptors is due to differential glycosylation
D E Grigoriadis, E B De Souza
The Journal of Biological Chemistry
|
August 5, 1988
The brain corticotropin-releasing factor (CRF) receptor is of lower apparent molecular weight than the CRF receptor in anterior pituitary. Evidence from chemical cross-linking studies
D E Grigoriadis, E B De Souza
European Journal of Pharmacology
|
July 15, 1993
Monoamine oxidase inhibitors inhibit [3H]quinpirole binding in rat striatal membranes
B Levant, D E Grigoriadis, E B DeSouza
FEBS Letters
|
December 1, 1986
Photoaffinity labelling of dopamine D2 receptors by [3H]azidomethylspiperone
H B Niznik, D E Grigoriadis, P Seeman
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1993
[3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study
B Levant, D E Grigoriadis, E B DeSouza
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1992
Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain
B Levant, D E Grigoriadis, E B DeSouza
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 1, 1989
Effects of chronic antidepressant and benzodiazepine treatment on corticotropin-releasing-factor receptors in rat brain and pituitary
D E Grigoriadis, D Pearsall, E B De Souza
Current Pharmaceutical Design
|
April 24, 1999
Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications
J R McCarthy, S C Heinrichs, D E Grigoriadis
European Journal of Pharmacology
|
May 24, 1995
Relative affinities of dopaminergic drugs at dopamine D2 and D3 receptors
B Levant, D E Grigoriadis, E B De Souza
Page
of 5